Expert Review of Respiratory Medicine

Papers
(The TQCC of Expert Review of Respiratory Medicine is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
False-positive and false-negative COVID-19 cases: respiratory prevention and management strategies, vaccination, and further perspectives95
Extrapulmonary tuberculosis84
Pulmonary fibrosis secondary to COVID-19: a narrative review78
Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential43
Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management41
Pre-existing COPD is associated with an increased risk of mortality and severity in COVID-19: a rapid systematic review and meta-analysis38
The COVID-19 pandemic: a target for surfactant therapy?34
Pseudomonas aeruginosa in bronchiectasis: infection, inflammation, and therapies31
Development of elexacaftor – tezacaftor – ivacaftor: Highly effective CFTR modulation for the majority of people with Cystic Fibrosis28
Nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex - disease burden, unmet needs, and advances in treatment developments27
Strategies for the prevention, diagnosis and treatment of COPD in low- and middle- income countries: the importance of primary care25
Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids?24
COVID-19 Smart Diagnosis in the Emergency Department: all-in in Practice23
Chronic obstructive pulmonary disease in HIV22
The right interface for the right patient in noninvasive ventilation: a systematic review22
Pulmonary fibrosis associated with rheumatoid arthritis: from pathophysiology to treatment strategies21
Extra-pulmonary manifestations of COPD and the role of pulmonary rehabilitation: a symptom-centered approach21
Cardiorespiratory and skeletal muscle damage due to COVID-19: making the urgent case for rehabilitation20
Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy20
Mediastinal lymphadenopathy: a practical approach20
Sleep apnea is associated with the increase of certain genera of Ruminococcaceae and Lachnospiraceae in the gut microbiome of hypertensive patients20
COVID-19 patients require multi-disciplinary rehabilitation approaches to address persisting symptom profiles and restore pre-COVID quality of life19
Ibuprofen and COVID-19 disease: separating the myths from facts18
Tuberculosis in children with severe acute malnutrition18
Impact of the COVID-19 pandemic on the management of chronic noninfectious respiratory diseases17
Lung function parameters among Australian Aboriginal ‘apparently healthy’ adults: an Australian Caucasian and Global Lung Function Initiative (GLI-2012) various ethnic norms comparative study17
Outcomes of acute respiratory distress syndrome in COVID-19 patients compared to the general population: a systematic review and meta-analysis17
Influences of environmental exposures on preterm lung disease17
Critical analysis of spirometric patterns in correlation to chest computed tomography among adult Indigenous Australians with chronic airway diseases17
DNA methylation in pulmonary fibrosis and lung cancer16
Does methylprednisolone reduce the mortality risk in hospitalized COVID-19 patients? A meta-analysis of randomized control trials16
Machine learning in asthma research: moving toward a more integrated approach16
Current state of the art and future perspectives with immunotherapy in the management of small cell lung cancer15
Pediatric bronchoscopy: recent advances and clinical challenges14
HIV TB coinfection - perspectives from India13
Functional tests associated with sarcopenia in moderate chronic obstructive pulmonary disease13
Management of progressive pulmonary fibrosis associated with connective tissue disease12
Not all nebulizers are created equal: Considerations in choosing a nebulizer for aerosol delivery during mechanical ventilation12
Prediction of stroke-associated pneumonia by the A2DS2, AIS-APS, and ISAN scores: a systematic review and meta-analysis12
A comprehensive clinical guide forPneumocystis jiroveciipneumonia: a missing therapeutic target in HIV-uninfected patients12
Role of acute exacerbations in skeletal muscle impairment in COPD12
An effective drug against COVID-19: reality or dream?12
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry12
The diagnostic value of CEA for lung cancer-related malignant pleural effusion in China: a meta-analysis12
COPD in Biomass exposed nonsmokers: a different phenotype12
Effectiveness, safety and efficacy of INTELLiVENT–adaptive support ventilation, a closed–loop ventilation mode for use in ICU patients – a systematic review12
Clinical characteristics and outcomes of hospitalized COVID-19 patients with COPD12
SARS-CoV-2 variants of concern and vaccine escape, from Alpha to Omicron and beyond12
COVID-19 clinical phenotypes and short-term outcomes: differences between the first and the second wave of pandemic in Italy12
Bilevel and continuous positive airway pressure and factors linked to all-cause mortality in COVID-19 patients in an intermediate respiratory intensive care unit in Italy12
Health impact of e-cigarettes and heated tobacco products in chronic obstructive pulmonary disease: current and emerging evidence11
Association between sarcoidosis and diabetes mellitus: a systematic review and meta-analysis11
Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study11
Comorbidities and mortality risk factors for patients with bronchiectasis11
COVID-19 first anniversary review of cases, hospitalization, and mortality in the UK11
Ten things you need to know about intensive care unit management of mechanically ventilated patients with COVID-1911
Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy11
Obstructive sleep apnea: personalizing CPAP alternative therapies to individual physiology11
Cognitive function and life quality of patients with moderate-to-severe obstructive sleep apnea-hypopnea syndrome in China10
Myofunctional therapy for OSA: a meta-analysis10
Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, BAP-65, PLR, NLR10
Transbronchial Lung Cryobiopsy in children10
Identification and management of connective tissue disease-associated interstitial lung disease: evidence-based Japanese consensus statements10
The Glasgow Prognostic Score and fibrinogen to albumin ratio as prognostic factors in hospitalized patients with COVID-1910
Management of acute upper respiratory tract infection: the role of early intervention10
COVID-19 ‘asymptomatic’ patients: an old wives’ tale9
Masks in COVID-19: let’s unmask the evidence9
Advances in understanding of mechanisms related to increased cardiovascular risk in COPD9
Immune checkpoint inhibitors: a new landscape for extensive stage small cell lung cancer treatment9
Management of COVID-19 from the pulmonologist’s perspective: a narrative review9
Step-up and step-down approaches in the treatment of asthma9
A multidisciplinary approach to the management of nontuberculous mycobacterial lung disease: a clinical perspective9
Predictive biomarkers for response to omalizumab in patients with severe allergic asthma: a meta-analysis9
Non-tuberculous mycobacteria: a disease beyond TB and preparedness in India9
A multimodal approach to detect and monitor early lung disease in cystic fibrosis8
Socioeconomic determinants of respiratory health in patients with cystic fibrosis: implications for treatment strategies8
Overprescription of short-acting β2-agonists is associated with poor asthma symptom control: results from five Middle Eastern countries included in the SABINA International (III) study8
High-flow versus conventional nasal cannula oxygen supplementation therapy and risk of hypoxia in gastrointestinal endoscopies: a systematic review and meta-analysis8
Association of mild cognitive impairment and characteristic of COPD and overall health status in a cohort study8
A narrative review of nontuberculous mycobacterial pulmonary disease: microbiology, epidemiology, diagnosis, and management challenges8
Insight into diagnosis of pleural tuberculosis with special focus on nucleic acid amplification tests8
The use of tobramycin for Pseudomonas aeruginosa: a review8
An expert overview of pulmonary fibrosis in sarcoidosis8
Recommendations for COPD management in Central and Eastern Europe8
Managing cystic fibrosis in children aged 6-11yrs: a critical review of elexacaftor/tezacaftor/ivacaftor combination therapy8
IL-26 in asthma and COPD8
Therapeutic effect of statins on airway remodeling during asthma7
Asthma and COPD medicines prescription-claims: A time-series analysis of England’s national prescriptions during the COVID-19 pandemic (Jan 2019 to Oct 2020)7
LncRNA HOXC-AS3 increases non-small cell lung cancer cell migration and invasion by sponging premature miR-967
Effects of different corticosteroid therapy on severe COVID-19 patients: a meta-analysis of randomized controlled trials7
Factors and mechanisms contributing to the development of preschool wheezing disorders7
Understanding hydrogen sulfide signaling in neonatal airway disease7
Chest radiographs may assist in predicting the outcome in the early phase of Covid-19. UK district general hospital experience of Covid-19 first wave7
The individual and societal prices of non-adherence to continuous positive airway pressure, contributors, and strategies for improvement7
Influenza and pneumonia-attributed deaths among cancer patients in the United States; a population-based study7
Personal protective equipment in the siege of respiratory viral pandemics: strides made and next steps7
Real-life survey on severe asthma patients during COVID-19 lockdown in Italy7
The emerging role of mycophenolate mofetil in interstitial lung diseases7
Novel therapeutic approaches targeting endotypes of severe airway disease7
Severe pediatric asthma endotypes: current limits and future perspectives7
The ‘clinically significant’ bronchodilator responsiveness (BDR) in children: a comparative study between six definitions of scholarly societies and a mini-review6
Impact of renal function on the prognosis of acute pulmonary embolism patients: a systematic review and meta-analysis6
Diagnostic value of fractional exhaled nitric oxide in differentiating the asthma-COPD overlap from COPD: a systematic review and meta-analysis6
Pharmacotherapy for obstructive sleep apnea: targeting specific pathophysiological traits6
Obstructive sleep apnea and cardiovascular events in elderly patients6
Predictors of invasive mechanical ventilation in hospitalized COVID-19 patients: a retrospective study from Jordan6
Redox signaling and antioxidant therapies in acute respiratory distress syndrome: a systematic review and meta-analysis6
Thoracic ultrasound-guided real-time pleural biopsy in the diagnosis of pleural diseases: a systematic review and meta-analysis6
Clinico-pathological features in fatal COVID-19 infection: a preliminary experience of a tertiary care center in North India using postmortem minimally invasive tissue sampling6
Prediction value of procalcitonin combining CURB-65 for 90-day mortality in community-acquired pneumonia6
Vascular endothelial damage in COPD: current functional assessment methods and future perspectives6
Effects of select dietary supplements on the prevention and treatment of viral respiratory tract infections: a systematic review of randomized controlled trials6
Reorganizing the respiratory high dependency unit for pandemics6
The impacts of parity on spirometric parameters: a systematic review6
0.03913402557373